Comparison the Efficacy of Four Different Alpha Blockers in the Treatment of Benign Prostatic Hyperplasia

27 Journal of Clinical and Analytical Medicine | Doğan Atılgan, Adem Yaşar, Fikret Erdemir, Bekir Süha Parlaktaş, Nihat Uluocak, Fatih Fırat Üroloji Anabilim Dalı, Gaziosmanpaşa Üniversitesi, Tıp Fakültesi, Tokat, Türkiye. Benign Prostat Hiperplazisi Tedavisinde Alfa Blokör Tedavisi The Alpha Blockers in the Treatment of Benign Prostatic Hyperplasia Benign Prostat Hiperplazisi Tedavisinde Kullanılan Dört Alfa Blokör Ajanın Etkinliklerinin Karşılaştırılması

[1]  C. Roehrborn,et al.  α1‐Adrenoceptor subtypes and lower urinary tract symptoms , 2008, International journal of urology : official journal of the Japanese Urological Association.

[2]  M. Emberton,et al.  Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk , 2007, BJU international.

[3]  Z. Ye,et al.  [Comparison of different drugs on the treatment of benign prostate hyperplasia]. , 2007, Zhonghua wai ke za zhi [Chinese journal of surgery].

[4]  W. Hellstrom,et al.  Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. , 2006, The Journal of urology.

[5]  K. McVary.  BPH: epidemiology and comorbidities. , 2006, The American journal of managed care.

[6]  T. Wilt,et al.  Alfuzosin for treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: a systematic review of efficacy and adverse effects. , 2005, Urology.

[7]  John T. Wei,et al.  Urologic diseases in America project: benign prostatic hyperplasia. , 2005, The Journal of urology.

[8]  R. Mongeau,et al.  Evaluation of Tamsulosin and Alfuzosin Activity in the Rat Vas Deferens: Relevance to Ejaculation Delays , 2005, Journal of Pharmacology and Experimental Therapeutics.

[9]  A. Kiper,et al.  Benign Prostat Hiperplazisinin Semptomatik Tedavisinde Doksazosin ve Terazosinin Etkinlik ve Yan Etki Karşılaştırması , 2005 .

[10]  Ç. Dinçel,et al.  Terazosin and Doxazosin in the Treatment of BPH: Results of a Randomized Study with Crossover in Non-Responders , 2004, Urologia internationalis.

[11]  L. Alexandre,et al.  A comparison of the effects of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rats , 2004, BJU international.

[12]  E. Akbay,et al.  A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes. , 2004, Scandinavian journal of urology and nephrology.

[13]  K. Andersson,et al.  Ejaculatory dysfunction: why all α‐blockers are not equal , 2003, BJU international.

[14]  A. Ahmed,et al.  Effect of Terazosin on Clinical Benign Prostatic Hyperplasia in Older Adults , 2003, Journal of the American Geriatrics Society.

[15]  AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. , 2003, The Journal of urology.

[16]  J. Nickel,et al.  Impact of medical therapy on transurethral resection of the prostate: a decade of change. , 2001, Urology.

[17]  H. Lepor,et al.  Long-term, open-label, phase III multicenter study of tamsulosin in benign prostatic hyperplasia. , 2001, Urology.

[18]  R. Kirby,et al.  The natural history of benign prostatic hyperplasia: what have we learned in the last decade? , 2000, Urology.

[19]  L S Mulcahy,et al.  An Investigation of the Uroselective Properties of Four Novel α1a-Adrenergic Receptor Subtype-Selective Antagonists , 2000 .

[20]  K. Andersson,et al.  Sympathetic pathways and adrenergic innervation of the penis , 2000, International Journal of Impotence Research.

[21]  M. Marberger,et al.  A Meta-Analysis on the Efficacy and Tolerability of α1-Adrenoceptor Antagonists in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction , 1999, European Urology.

[22]  F. Lowe.  Alpha–1–adrenoceptor blockade in the treatment of benign prostatic hyperplasia , 1999, Prostate Cancer and Prostatic Diseases.

[23]  H. Lepor.  Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group. , 1998, Urology.

[24]  F. Gu,et al.  Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group. , 1998, Journal of medicine.

[25]  J. Oesterling,et al.  The prevalence of prostatism: a population-based survey of urinary symptoms. , 1993, The Journal of urology.

[26]  M. Barry,et al.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. , 1992, The Journal of urology.

[27]  M. Caine.  Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia. , 1990, The Urologic clinics of North America.

[28]  J. McNeal,et al.  Pathology of benign prostatic hyperplasia. Insight into etiology. , 1990, The Urologic clinics of North America.

[29]  M. Barry,et al.  Epidemiology and natural history of benign prostatic hyperplasia. , 1990, The Urologic clinics of North America.

[30]  C. Wilson,et al.  Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate. , 1990, Endocrinology.

[31]  L. Kuller,et al.  Cigarette smoking and serum sex hormones in men. , 1988, American journal of epidemiology.

[32]  P. Abrams,et al.  Bladder outflow obstruction treated with phenoxybenzamine. , 1982, British journal of urology.

[33]  J. Andersen.  Prostatism. III. Detrusor hyperreflexia and residual urine. Clinical and urodynamic aspects and the influence of surgery on the prostate. , 1982, Scandinavian journal of urology and nephrology.

[34]  M. Caine,et al.  Phenoxybenzamine for benign prostatic obstruction. Review of 200 cases. , 1981, Urology.

[35]  T. Mann,et al.  Male reproductive function and semen. , 1981 .

[36]  R. Anikwe.  Patterns of urinary flow in benign prostatic hypertrophy. , 1976, International surgery.

[37]  F. Greenway,et al.  Estrogen-androgen imbalance in hepatic cirrhosis. Studies in 13 male patients. , 1973, Annals of internal medicine.